SCHEMBL19928701

SCHEMBL19928701

C#CC(=O)NC(CCCCCCC)CCCCCCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2C Q5R387 2/20 0.46
THRA P10827 1/20 0.43
THRB P10828 1/20 0.43
GNAI3 P08754 1/20 0.41
GNAO1 P09471 1/20 0.41
GNAI1 P63096 1/20 0.41
GPR84 Q9NQS5 5/20 0.41
FFAR1 O14842 1/20 0.41
EPHX1 P07099 3/20 0.41
ZDHHC7 Q9NXF8 1/20 0.41
PLA2G2A P14555 1/20 0.40
MAPT P10636 1/20 0.40
RRM1 P23921 1/20 0.40
LCK P06239 1/20 0.40
PPARD Q03181 1/20 0.40
ZDHHC20 Q5W0Z9 1/20 0.40
ZDHHC2 Q9UIJ5 1/20 0.40
DPP7 Q9UHL4 1/20 0.40
MEN1 O00255 1/20 0.39
FAAH O00519 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21389789 1.00 PLA2G2C (0.46) PLA2G2CTHRATHRBGNAI3GNAO1
SCHEMBL28496139 0.82 LPAR3 (0.49) PLA2G2A
SCHEMBL11606057 0.76 PLA2G2C (0.64) PLA2G2CGPR84FFAR1ZDHHC7PLA2G2A
SCHEMBL19271824 0.76 PLA2G2C (0.64) PLA2G2CGPR84FFAR1ZDHHC7PLA2G2A
SCHEMBL19271786 0.76 PLA2G2C (0.64) PLA2G2CGPR84FFAR1ZDHHC7PLA2G2A
SCHEMBL6940595 0.76 PLA2G2C (0.64) PLA2G2CGPR84FFAR1ZDHHC7PLA2G2A
SCHEMBL20459227 0.76 PLA2G2C (0.56) PLA2G2CGPR84FFAR1ZDHHC7MAPT
SCHEMBL5012513 0.76 PLA2G2C (0.56) PLA2G2CGPR84FFAR1ZDHHC7MAPT
SCHEMBL20459159 0.76 PLA2G2C (0.56) PLA2G2CGPR84FFAR1ZDHHC7MAPT
SCHEMBL9097264 0.76 PLA2G2C (0.56) PLA2G2CGPR84FFAR1ZDHHC7MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10723753-B2 Ras inhibitors and uses thereof DANA-FARBER CANCER INSTITUTE, INC. (US) 2020-07-28 US disclosed
US-20200199102-A1 COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF Revolution Medicines, Inc. 2020-06-25 US disclosed
US-20190112305-A1 BONE MARROW ON X CHROMOSOME KINASE (BMX) INHIBITORS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2019-04-18 US disclosed
US-10000483-B2 Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof DANA-FARBER CANCER INSTITUTE, INC. (US) 2018-06-19 US disclosed
US-9908872-B2 Methods to treat lymphoplasmacytic lymphoma DANA-FARBER CANCER INSTITUTE, INC. (US) 2018-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10000483-B2 Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof BMX, MELK, TEC PLA2G2C 1754/4885THRA 1839/4885THRB 1175/4885
US-10723753-B2 Ras inhibitors and uses thereof KRAS, NRAS, RASGRP1 PLA2G2C 306/4885THRA 3631/4885THRB 2872/4885
US-20190112305-A1 BONE MARROW ON X CHROMOSOME KINASE (BMX) INHIBITORS AND USES THEREOF BMX, MELK, TEC PLA2G2C 1754/4885THRA 1839/4885THRB 1175/4885
US-20200199102-A1 COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF PIN1, FKBP14, FKBP2 PLA2G2C 2847/4885THRA 4414/4885THRB 3929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.